Eton Pharmaceuticals, Inc. (NASDAQ:ETON) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Eton Pharmaceuticals, Inc., a specialty ...

President Trump on Monday signed a series of health-focused executive actions, including one cracking down on ...

In this article, we are going to take a look at where Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stands against other firms that defied the market slump and recorded double-digit gains last week.

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty ...

Recursion Pharmaceuticals and other AI-focused biotech ... care technology and AI-driven biotech space, including Certara Inc., Schrodinger Inc., Simulations Plus Inc. and Absci Corp., also ...

In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands against other best growth stocks to buy according to billionaires. The stock market has ...

Two Sigma Securities LLC purchased a new stake in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC.

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company’s lead product candidate is IMCIVREE (setmelanotide), a rare ...

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

President Donald Trump said Tuesday that his administration will soon impose tariffs on pharmaceuticals coming from foreign countries, predicting drug companies will move their operations to the U.S..

95.45% of the stock is currently owned by institutional investors and hedge funds. Xenon Pharmaceuticals Inc, a neuroscience-focused biopharmaceutical company, engages in the development of ...

President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs he has already imposed on most goods entering the United States ...